Edition:
United States

NuVasive Inc (NUVA.OQ)

NUVA.OQ on NASDAQ Stock Exchange Global Select Market

66.77USD
23 Sep 2016
Change (% chg)

$-1.29 (-1.90%)
Prev Close
$68.06
Open
$68.07
Day's High
$68.47
Day's Low
$66.69
Volume
371,581
Avg. Vol
215,628
52-wk High
$69.00
52-wk Low
$36.81

Summary

Name Age Since Current Position

Gregory Lucier

52 2015 Chairman of the Board, Chief Executive Officer

Jason Hannon

44 2016 President, Chief Operating Officer, General Counsel

Patrick Miles

50 2016 Vice Chairman of the Board

Quentin Blackford

36 2014 Chief Financial Officer, Executive Vice President

Matthew Link

40 2013 Executive Vice President - U.S. Sales

Mike Paolucci

54 2014 Executive Vice President - Global Human Resources

Carol Cox

50 2015 Executive Vice President - External Affairs and Corporate Marketing

Jason Hanson

45 2015 Executive Vice President, Strategy, Corporate Development and General Counsel

Peter Leddy

51 2015 Executive Vice President - Human Resources and Corporate Integrity

Russell Powers

45 2012 Executive Vice President - International

Johnson Lai

2015 Chief Information Officer

Daniel Wolterman

58 2015 Director

Jack Blair

72 2001 Independent Director

Peter Farrell

73 2005 Independent Director

Robert Friel

60 2016 Independent Director

Lesley Howe

70 2004 Independent Director

Mike O'Halleran

2016 Independent Director

Donald Rosenberg

64 2016 Independent Director

Stacy Roughan

2016 Director, Investor Relations & Corporate Communications

Biographies

Name Description

Gregory Lucier

Mr. Gregory T. Lucier is Chief Executive Officer, Chairman of the Board of the Company. Mr. Lucier has over 25 years of executive management experience and served as Chairman of the Board and Chief Executive Officer of Life Technologies Corporation, a global biotechnology company, from May 2003 until their acquisition by Thermo Fisher Scientific Inc. in February 2014. Prior to joining Life Technologies, Mr. Lucier served as Chief Executive Officer and President at GE Medical Systems Information Technologies, Vice President for Global Services at GE Medical Systems and served as a corporate officer of the General Electric Corporation. He currently serves on the board of RainTree Oncology Services, is board chairman for Sanford-Burnham Medical Research Institute, and previously served on the Board of CareFusion Corporation until the completion of its acquisition by Becton Dickinson on March 17, 2015. Mr. Lucier received a Bachelor of Science Degree with high distinction in Industrial Engineering from Pennsylvania State University and a Master of Business Administration degree from Harvard Graduate School of Business Administration.

Jason Hannon

Mr. Jason M. Hannon serves as President, Chief Operating Officer, General Counsel of the Company. He was Executive Vice President - International of the Company. He previously served as Executive Vice President - Corporate Development, General Counsel and Secretary of NuVasive, Inc., since January 2010. Prior to that, Mr. Hannon served as our Senior Vice President of Corporate Development, General Counsel and Secretary from January 2009 to December 2009, as our Senior Vice President, General Counsel, and Secretary from January 2007 to December 2008, and as our Vice President of Legal Affairs and Secretary from June 2005 to January 2007. Prior to joining NuVasive, Mr. Hannon practiced corporate and transactional law at the law firms of Brobeck Phleger & Harrison LLP and Heller Ehrman LLP, specializing in mergers and acquisitions, public and private financing, joint ventures, licensing arrangements, and corporate governance matters. Mr. Hannon also served as a law clerk to the Honorable Jerome Farris of the U.S. Court of Appeals for the Ninth Circuit. Mr. Hannon received a B.A. degree from the University of California, Berkeley and a J.D. from Stanford Law School.

Patrick Miles

Mr. Patrick W. G. Miles serves as Vice Chairman of the Board of the Company. He was President, Chief Operating Officer, Director of NuVasive, Inc. He served as our President, Global Products and Services from October 2011 to February 2015 and as our President, Americas from January 2010 to September 2011. Prior to that, he served as our Executive Vice President of Product Marketing and Development from January 2007 to December 2009, as our Senior Vice President of Marketing from December 2004 to January 2007, and as our Vice President, Marketing from January 2001 to December 2004. Mr. Miles has over 20 years of experience in the orthopaedic industry. Mr. Miles has also served as Director of Marketing for ORATEC Interventions, Inc., a medical device company and as a Director of Marketing for Minimally Invasive Systems and Cervical Spine Systems for Medtronic Sofamor Danek, as well as serving in several positions with Smith & Nephew plc. Mr. Miles received a B.S. in Finance from Mercer University.

Quentin Blackford

Mr. Quentin Blackford is Chief Financial Officer, Executive Vice President of the NuVasive Inc, since August 1, 2014. Prior to that he served as Executive Vice President of Finance and Investor Relations since July 2012, and previously served as Vice President, Finance from January 2011 to June 2012. Mr. Blackford joined NuVasive in 2009 as our Corporate Controller and has more than 10 years of experience in the healthcare industry, including his time at Zimmer Holdings, Inc. where he held various roles and responsibilities, including the Director of Finance & Controller for Zimmer’s Dental Division where he was responsible for all finance, accounting and IT activities for the worldwide division. Prior to that he was responsible for the global corporate financial planning and analysis function at Zimmer. Mr. Blackford is a Certified Public Accountant and obtained Bachelor of Science degrees in both Accounting and Business Administration from Grace College.

Matthew Link

Mr. Matthew W. Link is Executive Vice President - U.S. Sales of NuVasive, Inc., since January 2013. Prior to that, Mr. Link served as our Executive Vice President of U.S. Sales from January 2013 to February 2015, as our Senior Vice President of Sales, East from January 2012 to December 2012, as our Area Vice President, South from April 2010 to December 2012 and as our Sales Director, Atlantic from January 2008 to March 2010. Mr. Link joined NuVasive as our Area Business Manager for Virginia and Tennessee in May 2006. Prior to joining NuVasive, Mr. Link worked for DePuy as a sales representative from July 2002 to March 2004 in their orthopaedics division and as a territory manager in their spine division from March 2004 to May 2006. Mr. Link received a B.S. in Education from the University of Virginia.

Mike Paolucci

Mr. Mike Paolucci is the Executive Vice President - Global Human Resources of the NuVasive Inc. Mike Paolucci joins NuVasive from Life Technologies Corporation™, a global life sciences company with over $4 billion in revenue, which was recently acquired by Thermo Fisher Scientific. He brings more than 20 years of broad global human resources experience at the executive and board level that will be instrumental to NuVasive's evolution into a larger, global business. At Life Technologies, Paolucci was responsible for the global compensation and benefit programs that encompassed more than 10,000 employees in nearly 40 countries. He also served as a human resources business partner for various business segments and was responsible for the Company's human resources technology systems. Prior to Life Technologies, he served as Vice President in various human resources capacities at Hewlett-Packard and EDS Corporation, from 2000 to 2009.

Carol Cox

Ms. Carol A. Cox is Executive Vice President - External Affairs and Corporate Marketing of the Company. She was Executive Vice President - Strategy, Corporate Development of Nuvasive inc. She previously served as Executive Vice President - Strategy and Corporate Communications of the NuVasive Inc. Prior to that, she served as our Executive Vice President, Strategy and Corporate Communications since joining NuVasive in July of 2014. Before joining NuVasive, Ms. Cox served as Senior Vice President of External Affairs and Corporate Communications at Sanford-Burnham Medical Research Institute from March 2014 to July 2014. Prior to Sanford-Burnham, she served at Life Technologies Corporation as Senior Vice President of External Affairs and Corporate Communications from October 2012 to February 2014 and as Vice President and Head of Investor Relations from December 2011 to September 2012. Before joining Life Technologies, Ms. Cox was Vice President of Investor Relations at CareFusion Corporation from June 2009 to November 2011 and Senior Vice President for Global Corporate Communications and Investor Relations at Barr Pharmaceuticals from October 2006 to February 2009. She holds a bachelor’s degree in foreign affairs from the University of Virginia and a certificate in Investor Relations from The University of Connecticut School of Business.

Jason Hanson

Mr. Jason D. Hanson is Executive Vice President - Strategy, Corporate Development and General Counsel of the Company. Mr. Hanson brings to NuVasive more than 20 years of experience as a well-rounded business leader and legal advisor to healthcare companies. He joins NuVasive from General Electric (GE), where he served as a Corporate Vice President and a member of the senior executive team at GE Healthcare. Mr. Hanson's career includes law firm, government and corporate experience. He previously served as Corporate Vice President, Chief Risk Officer and General Counsel of GE Healthcare where he had global business responsibility for legal, compliance, government relations, enterprise risk management and various key corporate development activities. Prior to joining GE Healthcare, Mr. Hanson served as Company Group Chairman and Executive Vice President at Valeant Pharmaceuticals with responsibility for the company's Consumer, Ophthalmology, Latin American and Dental businesses, as well as the manufacturing and supply chain, R&D, regulatory and medical affairs teams. Previously, he served as Executive Vice President and Chief Operating Officer at Medicis Pharmaceutical Corporation following his tenure as the company's Executive Vice President, General Counsel and Corporate Secretary. Prior to that, Mr. Hanson served as General Counsel for GE Healthcare Technologies where he was responsible for global legal affairs. Mr. Hanson began his career with the law firm of Arnold & Porter in Washington, D.C. and later served as a prosecutor in the National Criminal Enforcement Section of the Antitrust Division of the U.S. Department of Justice. He received a bachelor's degree from Cornell University and a law degree from Duke University School of Law.Mr. Hanson will be based at NuVasive's corporate headquarters in San Diego, California.

Peter Leddy

Dr. Peter Michael Leddy, Ph.D., is an Executive Vice President - Human Resources and Corporate Integrityof the Company. He was Independent Director of NuVasive, Inc., effective as of July 9, 2015. Dr. Leddy has extensive knowledge and experience in human resources management with over 15 years in senior management positions. Dr. Leddy has served as Chief Human Resources Officer for the Taylor Made Golf Company since October 2014. From July 2005 to February 2014, Dr. Leddy served as Chief Human Resources Officer at Life Technologies Corporation, a global life sciences company with over $4 billion in revenue and over 10,000 employees that was acquired by Thermo Fisher Scientific. From 2000 to 2005, Dr. Leddy held several senior management positions with Dell Incorporated, where he was responsible for leading global talent and human resources in the Americas, overseeing 7,500 employees. From 1999 to 2000, Dr. Leddy served as the Executive Vice President for Human Resources at Promus Hotel Corporation, and from 1989 to 1999, he held a variety of executive and human resource positions at PepsiCo, Inc. Dr. Leddy serves on the board of directors of Pathway Genomics Corporation.

Russell Powers

Mr. Russell A. Powers is Executive Vice President - International of NuVasive, Inc., since October 2012. Prior to that, Mr. Powers served as our Senior Vice President, Operations from April 2012 to October 2012 and our Senior Vice President, Spinal & Biologics from April 2010 through April 2012. Mr. Powers served in various capacities at Medtronic Sofamor Danek during his thirteen years with the company, most recently as Vice President, U.S. Sales Operations from May 2009 to April 2010 and as Vice President, International from May 2003 to April 2009. Mr. Powers began his career in orthopaedics with Smith & Nephew as a member of the Trauma Marketing team. Mr. Powers received a B.B.A. from the University of Memphis.

Johnson Lai

Mr. Johnson Lai has been appointed as Chief Information Officer of NuVasive, Inc. Mr. Lai has more than 20 years of IT leadership experience and brings to the role extensive expertise in advancement of enterprise IT initiatives. Most recently, he was Vice President of IT at Thermo Fisher Scientific where he was responsible for providing the IT leadership to the Laboratory Products business group, as well as being an executive member of the integration management team that governed the integration of Life Technologies into Thermo Fisher Scientific. In that capacity, Mr. Lai was responsible for driving processes that created a combined IT vision and successfully executing global programs that achieved the targeted revenue and cost synergy objectives. Additionally, he provided IT leadership for Thermo Fisher Scientific's corporate functions with a business centric approach, including the support of mergers and acquisitions, among other responsibilities. Previously, as a senior IT leader at Life Technologies, Mr. Lai was responsible for delivering critical IT projects, including a global ERP, e-commerce and IT integration of companies acquired. Prior to that, Mr. Lai was a global IT leader for Abbott Vascular where he led the deployment of a single instance global ERP system and further matured the IT infrastructure and data centers to world-class levels. Mr. Lai has a Bachelor of Science in Managerial Economics from the University of California at Davis and a Master of Business Administration with an emphasis in MIS, Accounting & Finance from the University of California at Davis.

Daniel Wolterman

Mr. Daniel J. Wolterman is Director of the Company. Mr. Wolterman has been President and CEO of Memorial Hermann Health System since 2002. He has more than 30 years of experience in the healthcare industry and a long history of community involvement. He serves on the Joint Commission’s Center for Transforming Healthcare Leadership Advisory Council, and he continues to serve on the Greater Houston Partnership, and Voluntary Hospitals of America boards of directors. He previously served on the board of directors of Volcano Corporation until the completion of its acquisition by Royal Philips in February of this year. Mr. Wolterman is also an Adjunct Professor at The University of Texas School of Public Health. Mr. Wolterman earned a B.S. degree in Business Administration in 1979 and a M.B.A. in Finance in 1980 from the University of Cincinnati and a Master’s Degree in Healthcare Administration from Xavier University in 1982.

Jack Blair

Mr. Jack R. Blair is an Independent Director of NuVasive, Inc., since August 2001. During his 18-year career with Smith & Nephew plc ending in 1998, Mr. Blair served in various capacities with Smith & Nephew plc and Richards Medical Company, which was acquired by Smith & Nephew in 1986, most recently as group president of its North and South America and Japan operations. He held the position of President of Richards Medical Company. Until November 2007, when the company was sold, Mr. Blair served as chairman of the board of directors of DJO Global, Inc., an orthopaedic medical device company. Mr. Blair holds a B.A. in Government from Miami University and an M.B.A. from the University of California, Los Angeles.

Peter Farrell

Dr. Peter C. Farrell, Ph.D., is an Independent Director of NuVasive, Inc., since January 2005. Dr. Farrell is founding Chairman of ResMed, Inc. a leading developer and manufacturer of medical equipment for the diagnosis and treatment of sleep-disordered breathing, and has been a director and chairman of the board since its inception in June 1989. He served as Chief Executive Officer of ResMed from 1990 to 2007 and again from February 2011 until March 2013. From March 2013 through December 2013, Dr. Farrell served as executive chairman of ResMed, and, in January 2014, he became non-executive chairman. Dr. Farrell also serves on the board of directors of Mikroscan Technologies, Inc. In addition, Dr. Farrell is a member of the National Academy of Engineering. Dr. Farrell holds bachelor’s and master’s degrees in chemical engineering from the University of Sydney and the Massachusetts Institute of Technology, a Ph.D. in bioengineering from the University of Washington, Seattle and a Doctor of Science from the University of New South Wales for research related to dialysis and renal medicine.

Robert Friel

Mr. Robert F. Friel is Independent Director of the Company. currently serves as Chairman, Chief Executive Officer and President of PerkinElmer, Inc. Prior to being appointed President and Chief Executive Officer in February 2008 and Chairman in April 2009, he had served as President and Chief Operating Officer since August 2007, and as Vice Chairman and President of PerkinElmer’s Life and Analytical Sciences unit since January 2006. Mr. Friel was previously Executive Vice President and Chief Financial Officer of PerkinElmer, with responsibility for business development and information technology in addition to his oversight of finance functions, from October 2004 until January 2006. Mr. Friel joined PerkinElmer in February 1999 as Senior Vice President and Chief Financial Officer. Prior to joining PerkinElmer, he held several senior management positions with AlliedSignal, Inc., now Honeywell International. Mr. Friel received a Bachelor of Arts degree in economics from Lafayette College and a Master of Science degree in taxation from Fairleigh Dickinson University. Mr. Friel currently services as a member of the Board of Directors of Xylem, Inc. and previously served on the Board of Directors of CareFusion Corporation prior to its acquisition by Becton, Dickinson and Company in 2015.

Lesley Howe

Mr. Lesley H. Howe is an Independent Director of NuVasive, Inc., since February 2004. Mr. Howe has over 40 years of experience in accounting, finance and business management within a variety of industries. Mr. Howe had a 30-year career with KPMG Peat Marwick LLP, an international accounting and auditing firm, in which he was an audit partner for 23 years and an area managing partner/managing partner of the Los Angeles office of KPMG for three years. Mr. Howe currently serves on the board of directors of Jamba, Inc., the leading retailer of quality blended fruit beverages. He previously served on the board and was chair of the Audit Committee of DJ Orthopedics Inc. from 2002 through 2008 and served on the board of directors of Volcano Corporation until the completion of its acquisition by Royal Philips on February 17, 2015. Mr. Howe received a B.S. in business administration from the University of Arkansas. Mr. Howe’s extensive public accounting, financial and executive management background provide valuable financial and accounting experience and expertise to our Board.

Mike O'Halleran

Mr. Mike O'Halleran is Independent Director of the Company. He has more than 40 years of business experience, Mr. O'Halleran currently serves as the executive chairman of Aon Benfield and senior vice president of Aon, plc, a provider of risk management, insurance and consulting services. Mr. O'Halleran joined the Aon group of companies in 1987 to lead its reinsurance division and since that time, has served in several significant management positions including president and chief operating officer of Aon Corporation, and since August 2007, as the executive chairman of Aon Benfield. Prior to joining Aon, he was a senior executive with well-known companies in the insurance industry. Mr. O'Halleran brings extensive healthcare and medical device governance experience, having been a long-standing director of Cardinal Health and later CareFusion. Mr. O'Halleran has a degree in Accounting and Finance from the University of Wisconsin-Whitewater.

Donald Rosenberg

Mr. Donald J. Rosenberg, J.D., is Independent Director of the Company. He has served as Executive Vice President, General Counsel and Corporate Secretary of Qualcomm Incorporated since October 2007. In this role, he is responsible for overseeing Qualcomm’s worldwide legal affairs including litigation, intellectual property and corporate matters. Prior to joining Qualcomm, Mr. Rosenberg served as Senior Vice President, General Counsel and Corporate Secretary of Apple Inc. from December 2006 until October 2007. From May 1975 to November 2006, Mr. Rosenberg held numerous positions at IBM Corporation, including Senior Vice President and General Counsel. Mr. Rosenberg received a Bachelor of Science degree in mathematics from the State University of New York at Stony Brook and his Juris Doctor from St. John’s University School of Law.

Stacy Roughan